Visser LH - Search Results

1

Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome.

Jacobs BC, van Doorn PA, Schmitz PI, Tio-Gillen AP, Herbrink P, Visser LH, Hooijkass H, van der Meché FG. Jacobs BC, et al. Among authors: visser lh. Ann Neurol. 1996 Aug;40(2):181-7. doi: 10.1002/ana.410400209. Ann Neurol. 1996. PMID: 8773599

2

Guillain-Barré syndrome without sensory loss (acute motor neuropathy). A subgroup with specific clinical, electrodiagnostic and laboratory features. Dutch Guillain-Barré Study Group.

Visser LH, Van der Meché FG, Van Doorn PA, Meulstee J, Jacobs BC, Oomes PG, Kleyweg RP, Meulstee J. Visser LH, et al. Brain. 1995 Aug;118 ( Pt 4):841-7. doi: 10.1093/brain/118.4.841. Brain. 1995. PMID: 7655882

3

Cytomegalovirus infection and Guillain-Barré syndrome: the clinical, electrophysiologic, and prognostic features. Dutch Guillain-Barré Study Group.

Visser LH, van der Meché FG, Meulstee J, Rothbarth PP, Jacobs BC, Schmitz PI, van Doorn PA. Visser LH, et al. Neurology. 1996 Sep;47(3):668-73. doi: 10.1212/wnl.47.3.668. Neurology. 1996. PMID: 8797462

4

Guillain-Barré syndrome: multifactorial mechanisms versus defined subgroups.

van der Meché FG, Visser LH, Jacobs BC, Endtz HP, Meulstee J, van Doorn PA. van der Meché FG, et al. Among authors: visser lh. J Infect Dis. 1997 Dec;176 Suppl 2:S99-102. doi: 10.1086/513779. J Infect Dis. 1997. PMID: 9396690 Review.

5

Risk factors for treatment related clinical fluctuations in Guillain-Barré syndrome. Dutch Guillain-Barré study group.

Visser LH, van der Meché FG, Meulstee J, van Doorn PA. Visser LH, et al. J Neurol Neurosurg Psychiatry. 1998 Feb;64(2):242-4. doi: 10.1136/jnnp.64.2.242. J Neurol Neurosurg Psychiatry. 1998. PMID: 9489539 Free PMC article. Clinical Trial.

6

Prognostic factors of Guillain-Barré syndrome after intravenous immunoglobulin or plasma exchange. Dutch Guillain-Barré Study Group.

Visser LH, Schmitz PI, Meulstee J, van Doorn PA, van der Meché FG. Visser LH, et al. Neurology. 1999 Aug 11;53(3):598-604. doi: 10.1212/wnl.53.3.598. Neurology. 1999. PMID: 10449126

7

Cytokines in the muscle tissue of idiopathic inflammatory myopathies: implications for immunopathogenesis and therapy.

Megens-de Letter MA, Visser LH, van Doorn PA, Savelkoul HF. Megens-de Letter MA, et al. Among authors: visser lh. Eur Cytokine Netw. 1999 Dec;10(4):471-8. Eur Cytokine Netw. 1999. PMID: 10586113 Free article. Review.

8

Distinctions between critical illness polyneuropathy and axonal Guillain-Barré syndrome.

de Letter MA, Visser LH, van der Meché FG, Ang W, Savelkoul HF. de Letter MA, et al. Among authors: visser lh. J Neurol Neurosurg Psychiatry. 2000 Mar;68(3):397-8. doi: 10.1136/jnnp.68.3.397. J Neurol Neurosurg Psychiatry. 2000. PMID: 10787316 Free PMC article. No abstract available.

9

Critical illness polyneuropathy and myopathy (CIPNM): evidence for local immune activation by cytokine-expression in the muscle tissue.

De Letter MA, van Doorn PA, Savelkoul HF, Laman JD, Schmitz PI, Op de Coul AA, Visser LH, Kros JM, Teepen JL, van der Meché FG. De Letter MA, et al. Among authors: visser lh. J Neuroimmunol. 2000 Jul 1;106(1-2):206-13. doi: 10.1016/s0165-5728(99)00252-0. J Neuroimmunol. 2000. PMID: 10814799

10

HLA class I and II in Lambert-Eaton myasthenic syndrome without associated tumor.

Wirtz PW, Roep BO, Schreuder GM, van Doorn PA, van Engelen BG, Kuks JB, Twijnstra A, de Visser M, Visser LH, Wokke JH, Wintzen AR, Verschuuren JJ. Wirtz PW, et al. Among authors: visser lh. Hum Immunol. 2001 Aug;62(8):809-13. doi: 10.1016/s0198-8859(01)00270-1. Hum Immunol. 2001. PMID: 11476904

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

182 results

Search Page

Filters